Another study links mRNA COVID-19 vaccines to myocarditis
A recent entry concerned a Danish study indicating that mRNA COVID-19 vaccines have no statistically significant benefit for all-cause mortality, potentially killing as many people as they save due to cardiovascular adverse effects. Earlier, we had also reported on several other studies on the vaccines and myocarditis, as well as the restrictions placed on the Moderna vaccine in several countries due to cardiovascular risks.
Now there is another, Scandinavian, study finding a drastic increase in myocarditis (and pericarditis) risk after vaccination: “Results of this large cohort study indicated that both first and second doses of mRNA vaccines were associated with increased risk of myocarditis and pericarditis. For individuals receiving 2 doses of the same vaccine, risk of myocarditis was highest among young males (aged 16-24 years) after the second dose. These findings are compatible with between 4 and 7 excess events in 28 days per 100 000 vaccinees after BNT162b2 [Pfizer-BioNTech], and between 9 and 28 excess events per 100 000 vaccinees after mRNA-1273 [Moderna]. This risk should be balanced against the benefits of protecting against severe COVID-19 disease.” Source.
Okay then.
Extra: If there is a greater risk of adverse effects from the COVID-19 vaccines in the young, while COVID-19 itself is far more dangerous for the elderly, should COVID-19 vaccination be encouraged and even forced on all segments of the population? Will the claimed benefits still be considered to outweigh the risks if COVID-19 becomes increasingly benign, more people acquire natural immunity, and more adverse effects of the vaccines come to light?